H35.051
Retinal neovascularization, unspecified, right eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Retinal neovascularization refers to the formation of new blood vessels in the retina, which is the light-sensitive tissue at the back of the eye. When these abnormal vessels develop, they can pose risks to vision, potentially leading to complications such as bleeding or retinal detachment. The specific ICD-10 code H35.051 indicates that this condition is occurring in the right eye, but the precise cause and severity can vary. Understanding this condition can help patients better grasp the importance of medical evaluation and treatment to maintain eye health.
Causes & Symptoms
Clinical Causes: Diabetic retinopathy: A common cause of abnormal blood vessel growth due to prolonged high blood sugar levels. Retinal vein occlusion: Blockage of retinal veins that can lead to ischemia and new vessel formation. Age-related macular degeneration (particularly the neovascular or 'wet' type): Abnormal blood vessel growth due to aging processes. Ocular ischemic syndrome: Reduced blood flow to the eye, prompting new vessel development as a compensatory response. Other inflammatory or vascular conditions affecting the retina.
Key Symptoms: Sudden or gradual loss of vision in the right eye. Blurred or distorted vision, often described as straight lines appearing bent. Presence of floaters or dark spots in the visual field. Visual field loss or shadowing in parts of vision. Possible pain or discomfort is typically absent in early stages.
Diagnostic & Treatment
Diagnosis Path: Diagnosis commonly involves a comprehensive eye examination, which includes dilating the pupils to view the retina clearly. Specific tests may include:
Treatment Protocols: The approach to managing retinal neovascularization focuses on halting or reducing abnormal vessel growth, preventing bleeding, and preserving vision. Therapeutic options may include:
Clinical Advice & FAQs
Billing Guidance
Is H35.051 a billable ICD-10 code?
Yes, H35.051 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.051?
Clinical documentation must specify the nature of Retinal neovascularization, unspecified, right eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference